Introduction:Metabolic syndrome (MS) is characterized by multiple risk factors, including abnormal fat distribution, dyslipidemia, hypertension and hyperglycemia in relation to insulin resistance and obesity and persons with MS are considered to have high risk of cardiovascular diseases (CVD) and diabetes mellitus (DM). 1,2 Diabetes and cardiovascular diseases often appear as the two sides of a coin: on one side diabetes mellitus has been rated as an equivalent of coronary heart disease and conversely many patients with established coronary heart disease suffer from diabetes or pre-states. 3

No abstract